Absorption of N-acetylcysteine in Healthy and Mycoplasma gallisepticum-Infected Chickens

N-acetylcysteine (NAC) is widely used as a mucolytic agent in cases with inflammation of the lungs. NAC is applied in poultry with aflatoxin B1 intoxication as an antioxidant, but its pharmacokinetics are not known. The present study was conducted to characterize the population pharmacokinetics of orally administered NAC in broilers. It included 32 chickens, divided into four groups, treated with NAC at a dose rate of 100 mg/kg/day mixed with the feed: healthy broilers (n = 6); chickens infected with Mycoplasma gallisepticum (n = 10); healthy broilers (n = 6); and diseased chickens (n = 10) treated with NAC and doxycycline (via drinking water, 20 mg/kg body weight (b.w.)). Plasma concentrations were analyzed by Liquid Chromatography -Mass Spectrometry (MS)/MS. NAC was absorbed after oral administration in all four groups of chickens. In healthy chickens treated solely with NAC, maximum plasma concentrations of 2.26 & PLUSMN; 0.91 mu g mL(-1) were achieved at 2.47 & PLUSMN; 0.45 h after dosing. The value of absorption half-life was 1.04 & PLUSMN; 0.53 h. The population pharmacokinetic analysis showed that dose adjustment of NAC is not required in M. gallisepticum-infected broilers or when it is combined with doxycycline.

Automated summary

The study characterized the population pharmacokinetics of orally administered N-acetylcysteine (NAC) in broilers, showing that NAC was absorbed in all experimental chickens and reached maximum plasma concentrations in healthy chickens at 2.47±0.45 hours after dosing. The population pharmacokinetic analysis indicated no need for dose adjustment of NAC in M. gallisepticum-infected broilers or when combined with doxycycline.